Published on

Medicine - Immunoglobulin D (IgD)

Immunoglobulin D (IgD) is an antibody class primarily expressed on the surface of mature naive B lymphocytes, where it functions as part of the B-cell receptor (BCR) complex.

IgD is involved in antigen recognition and regulation of B-cell activation. Its biological functions are less completely understood than those of IgG, IgA, IgM and IgE.

Key Examination Associations
  • IgD is a monomer.
  • IgD contains delta (δ) heavy chains.
  • Expressed on mature naive B cells.
  • Usually co-expressed with IgM.
  • Functions as a B-cell antigen receptor.
  • Participates in B-cell activation.

1. Structure of IgD

A. Monomeric Structure

IgD is a monomer consisting of:

  • Two identical delta (δ) heavy chains.
  • Two identical light chains (kappa or lambda).
  • Two antigen-binding sites.

The variable regions recognise antigens, whereas the constant regions determine the immunoglobulin class.

B. Forms of IgD

  • Membrane-bound IgD: Expressed on B cells and functions as an antigen receptor.
  • Secreted IgD: Present in very low concentrations in serum and at certain mucosal sites.
Exam Point: IgD is a monomeric immunoglobulin expressed on mature naive B lymphocytes.

2. IgD Expression on B Lymphocytes

IgD is characteristically expressed on mature naive B cells, usually alongside IgM.

B-Cell Maturation Flowchart

Immature B Cell Surface IgM positive Mature Naive B Cell Surface IgM positive Surface IgD positive Antigen Recognition IgM / IgD B-cell receptors B-Cell Activation Additional signals may be needed B-Cell Differentiation Plasma cells / Memory B cells

Important Features

  • Immature B cells predominantly express IgM.
  • Mature naive B cells usually express both IgM and IgD.
  • IgM and IgD generally recognise the same antigen.
  • Co-expression results from alternative RNA splicing.
Important Distinction: Co-expression of IgM and IgD does not require class-switch recombination. It occurs through alternative RNA splicing of the same rearranged immunoglobulin transcript.

3. Role of IgD in B-Cell Activation

Membrane-bound IgD functions as part of the B-cell receptor complex.

Mechanism

  1. An antigen binds membrane-bound IgD.
  2. The B-cell receptor complex becomes activated.
  3. CD79a and CD79b transmit intracellular signals.
  4. B-cell signalling pathways are activated.
  5. With appropriate additional signals, the B cell may proliferate and differentiate.
Possible outcomes:
  • B-cell proliferation.
  • Plasma-cell differentiation.
  • Memory B-cell formation.
  • Antibody production.
Exam Point: IgD and IgM both function as antigen receptors on mature naive B cells. Full B-cell activation often requires additional helper T-cell signals.

4. Other Functions of IgD

A. Regulation of B-Cell Responses

IgD may influence:

  • B-cell responsiveness to antigens.
  • Activation thresholds.
  • Peripheral B-cell tolerance.
  • Responses to different antigen structures.

The precise functions of IgD remain an area of ongoing research.

B. Mucosal Immunity

  • Secreted IgD is present in certain mucosal tissues.
  • It may participate in local immune regulation.
  • It may interact with innate immune cells.
Important: IgA remains the principal immunoglobulin responsible for mucosal antibody protection.

5. Important Properties of IgD

  • Monomeric structure.
  • Contains delta heavy chains.
  • Expressed on mature naive B cells.
  • Usually co-expressed with IgM.
  • Functions as a B-cell antigen receptor.
  • Very low concentration in normal serum.
  • Does not significantly cross the placenta.
  • Not a major complement activator.
  • Not routinely measured in standard immunoglobulin testing.

6. Clinical Significance

A. B-Cell Maturation

  • Immature B cells: IgM positive, IgD low or absent.
  • Mature naive B cells: IgM positive and IgD positive.

This distinction is useful in B-cell immunophenotyping.

B. Hyper-IgD Syndrome

Hyper-IgD syndrome is a historical name for a phenotype of mevalonate kinase deficiency (MKD).

MKD is an autosomal recessive autoinflammatory disorder caused by pathogenic variants in the MVK gene.

Clinical features:
  • Recurrent fever.
  • Abdominal pain.
  • Lymphadenopathy.
  • Arthralgia.
  • Gastrointestinal symptoms.
Important Correction: Elevated IgD is not consistently present in mevalonate kinase deficiency and is not required for diagnosis.

7. Important Corrections

  1. IgD is a monomer containing delta heavy chains.
  2. IgD is mainly expressed on mature naive B cells.
  3. IgD is usually co-expressed with IgM.
  4. Membrane-bound IgD participates in antigen recognition.
  5. IgM/IgD co-expression occurs through alternative RNA splicing.
  6. Full B-cell activation may require additional signals.
  7. Secreted IgD may contribute to mucosal immune regulation.

8. High-Yield Examination Summary

Structure
  • Monomer.
  • Delta heavy chains.
Location
  • Mature naive B cells.
  • Co-expressed with IgM.
Function
  • Antigen recognition.
  • B-cell receptor signalling.
  • Regulation of B-cell activation.
Clinical Association
  • Mevalonate kinase deficiency.
  • Historically called hyper-IgD syndrome.
Most Important Examination Point: IgD is a monomeric immunoglobulin expressed alongside IgM on mature naive B cells, where it functions as an antigen receptor involved in B-cell activation.

Medicine - Immunology Revision Notes

Image description
0 Comments